$364 Million is the total value of New Leaf Venture Partners, L.L.C.'s 20 reported holdings in Q4 2018. The portfolio turnover from Q3 2018 to Q4 2018 was 0.0% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| DCPH | DECIPHERA PHARMACEUTICALS INC | $86,146,000 | -45.8% | 4,104,140 | 0.0% | 23.65% | -18.2% | |
| PRNB | PRINCIPIA BIOPHARMA INC | $71,918,000 | -6.3% | 2,625,713 | 0.0% | 19.74% | +41.4% | |
| APTX | APTYNIX INC | $54,418,000 | -42.9% | 3,290,079 | 0.0% | 14.94% | -13.8% | |
| STIM | NEURONETICS INC | $29,859,000 | -39.6% | 1,543,115 | 0.0% | 8.20% | -9.0% | |
| ARVN | ARVINAS INC | $29,337,000 | -23.8% | 2,283,048 | 0.0% | 8.05% | +14.9% | |
| WVE | WAVE LIFE SCIENCES LTD | $17,885,000 | -15.9% | 425,429 | 0.0% | 4.91% | +26.8% | |
| CRSP | CRISPR THERAPEUTICS AGnamen akt | $12,705,000 | -35.6% | 444,708 | 0.0% | 3.49% | -2.8% | |
| OBSV | OBSEVA SA | $11,400,000 | -29.8% | 900,501 | 0.0% | 3.13% | +5.9% | |
| UMRX | UNUM THERAPEUTICS INC | $7,900,000 | -57.3% | 1,795,545 | 0.0% | 2.17% | -35.5% | |
| ITRM | ITERUM THERAPEUTICS PLC | $7,296,000 | -24.4% | 1,456,303 | 0.0% | 2.00% | +14.1% | |
| SRRA | SIERRA ONCOLOGY INC | $6,627,000 | -22.4% | 5,020,446 | 0.0% | 1.82% | +17.1% | |
| AFMD | AFFIMED N V | $5,598,000 | -28.5% | 1,800,000 | 0.0% | 1.54% | +7.9% | |
| CRNX | CRINETICS PHARMACEUTICALS INC | $5,029,000 | +4.7% | 167,700 | 0.0% | 1.38% | +57.9% | |
| AVRO | Buy | AVROBIO INC | $3,589,000 | -59.9% | 215,550 | +25.1% | 0.98% | -39.5% |
| CMRX | Buy | CHIMERIX INC | $3,470,000 | -10.8% | 1,350,000 | +35.0% | 0.95% | +34.6% |
| PRTO | Buy | PROTEON THERAPEUTICS INC | $3,458,000 | +18.2% | 1,523,200 | +1.5% | 0.95% | +78.4% |
| VSAR | Sell | ARAVIVE INC | $3,417,000 | -1.5% | 970,659 | -60.8% | 0.94% | +48.7% |
| NERV | Buy | MINERVA NEUROSCIENCES INC | $2,853,000 | +74.8% | 423,300 | +225.6% | 0.78% | +163.6% |
| EDGE | EDGE THERAPEUTICS INC | $753,000 | -60.8% | 2,344,868 | 0.0% | 0.21% | -40.9% | |
| AVEO | AVEO PHARMACEUTICALS INC | $643,000 | -51.7% | 402,118 | 0.0% | 0.18% | -26.9% |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2019-02-13
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| DECIPHERA THERAPEUTICS INC | 25 | Q3 2023 | 44.4% |
| CHIMERIX INC | 25 | Q1 2023 | 20.9% |
| SIERRA ONCOLOGY INC | 22 | Q2 2022 | 14.9% |
| ARVINAS INC | 21 | Q3 2023 | 44.8% |
| CRINETICS PHARMACEUTICALS INC | 21 | Q3 2023 | 11.4% |
| OBSEVA SA | 20 | Q4 2021 | 8.5% |
| AVROBIO INC | 20 | Q1 2023 | 1.7% |
| HARPOON THERAPEUTICS INC | 19 | Q3 2023 | 20.0% |
| ALECTOR INC | 19 | Q3 2023 | 4.6% |
| ITERUM THERAPEUTICS PLC | 18 | Q3 2022 | 3.8% |
View New Leaf Venture Partners, L.L.C.'s complete holdings history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-05-14 |
| 13F-HR | 2024-02-14 |
| 13F-HR | 2023-11-14 |
| 13F-HR | 2023-08-10 |
| 13F-HR | 2023-05-11 |
| 13F-HR | 2023-02-06 |
| 13F-HR | 2022-11-10 |
| 13F-HR | 2022-08-09 |
| 13F-HR | 2022-05-06 |
| 13F-HR | 2022-02-11 |
View New Leaf Venture Partners, L.L.C.'s complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.